Marshall Wace’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-19,600
Closed -$1.35M 2277
2023
Q2
$1.35M Buy
+19,600
New +$1.39M ﹤0.01% 1600
2023
Q1
Sell
-32,500
Closed -$3.03M 2745
2022
Q4
$3.03M Buy
+32,500
New +$3.14M 0.01% 1503
2021
Q2
Sell
-3,000
Closed -$226K 2721
2021
Q1
$226K Buy
+3,000
New +$219K ﹤0.01% 2219

Other funds holding CVS

Marshall Wace's CVS Position: Q1 2026 in Review

Marshall Wace increased its CVS Health (CVS) stake by 5,129% in Q1 2026, buying an estimated $61M and bringing the position to 807,534 shares worth $58M. The position accounts for 0.06% of the portfolio, ranked #314.

Marshall Wace first reported a position in CVS in Q2 2014 and has held it in 44 quarters since. The position peaked at $383M in Q4 2023. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Marshall Wace held 807,534 shares of CVS Health worth $58M as of Q1 2026.
  • Marshall Wace bought 792,090 CVS Health shares in Q1 2026, an estimated $61M.
  • CVS Health made up 0.06% of Marshall Wace's portfolio in Q1 2026, its #314 holding.
  • Marshall Wace first reported a position in CVS Health in Q2 2014 and has held it in 44 quarters since.
  • Marshall Wace's CVS Health position peaked at $383M in Q4 2023.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.